Medicare Enrolled
Dr. Sepehr Rejai, M.D.
Pain Medicine · Berkeley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rejai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rejai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rejai
Dr. Sepehr Rejai is a pain medicine specialist in Berkeley, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Rejai performed 3,882 Medicare services across 2,156 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rejai received a total of $60,580 from 9 pharmaceutical and/or device companies across 142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rejai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 23% volume in CA
$60,580 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,882
Medicare services
Top 23% in CA for pain medicine
2,156
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~324 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,226 | $114 | $364 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
266 | $160 | $489 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
222 | $11 | $212 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
171 | $113 | $464 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
154 | $148 | $554 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
150 | $57 | $1,055 |
| Injection, methylprednisolone acetate, 40 mg | 130 | $6 | $23 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
120 | $52 | $262 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
110 | $0 | $1 |
| Hyaluronan injection (Euflexxa) for joint An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space. |
108 | $101 | $436 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
102 | $194 | $2,206 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
98 | $109 | $1,245 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
98 | $111 | $1,153 |
| Peripheral nerve neurostimulator electrode insertion A procedure to place an electrode through the skin into a peripheral nerve. This electrode is part of a neurostimulator system used to deliver electrical impulses. |
98 | $223 | $925 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
98 | $60 | $961 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
96 | $63 | $568 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
79 | $46 | $475 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
55 | $112 | $1,115 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
54 | $0 | $4 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
52 | $64 | $543 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
50 | $285 | $2,054 |
| Psychological test evaluation, first hour A healthcare professional evaluates the results of psychological testing during an initial one-hour session. |
47 | $110 | $408 |
| New patient office visit, complex (60-74 min) | 46 | $187 | $697 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
37 | $176 | $2,025 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
36 | $60 | $930 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $81 | $247 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
29 | $54 | $677 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 27 | $94 | $540 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
26 | $46 | $684 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
23 | $95 | $1,126 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
18 | $9 | $38 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
14 | $532 | $3,815 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
12 | $4 | $14 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$60,580
Total received (2018-2024)
Avg $8,654/year across 7 years
Top 5% in CA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
9
Companies
142
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$55,688 (91.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,573 (5.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,319 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$23,528
2023
$26,980
2022
$9,268
2021
$280
2020
$84
2019
$283
2018
$158
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SPR Therapeutics, Inc
$23,117
Boston Scientific Corporation
$317
Saluda Medical Americas, Inc.
$70
Abbott Laboratories
$24
Top 3 companies account for 99.9% of 2024 payments
All-time payments by company (2018-2024) ›
SPR Therapeutics, Inc
$48,915
Vertos Medical, Inc.
$6,854
Boston Scientific Corporation
$4,174
BOSTON SCIENTIFIC CORPORATION
$315
Abbott Laboratories
$114
Nevro Corp.
$104
Saluda Medical Americas, Inc.
$70
Medtronic USA, Inc.
$18
Carl Zeiss Meditec, Inc.
$17
Top 3 companies account for 98.9% of all-time payments
Associated products mentioned in payments ›
COVEREDGE · ETERNA · Evoke · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · General - Pain Management · None Specified · Omnia · Proclaim Family of SCS IPGs · Proclaim IPG · RESTORE · SPECTRA WAVEWRITER · SPRINT PNS System · Senza · Superion · WaveWriter Alpha Prime 16 · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for pain medicine in CA.
Geographic Context
Pain medicines within 10 mi
16
Per 100K population
1.0
County median income
$126,240
Nearest hospital
ALTA BATES SUMMIT MEDICAL CENTER - ALTA BATES CAMP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rejai is a clinical cardiology specialist, with above-average Medicare volume (top 23% in CA), with consulting-driven industry engagement in the top 5% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rejai experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rejai performed 1,226 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rejai receive payments from pharmaceutical companies?
Yes. Dr. Rejai received a total of $60,580 from 9 companies across 142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rejai's costs compare to other pain medicines in Berkeley?
Dr. Rejai's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rejai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Berkeley
Browse pain medicines in Berkeley ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in CA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in CA
Which CA pain medicines receive the most from drug and device companies.
By company
SPR Therapeutics, Inc Payments to Doctors
See all physicians who received payments from SPR Therapeutics, Inc.
By company
Vertos Medical, Inc. Payments to Doctors
See all physicians who received payments from Vertos Medical, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology